Results

Total Results: 801 records

Showing results for "described".

141. Archived: Alcohol Misuse: Screening and Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/alcohol-misuse-screening-and-counseling-2004
     April 06, 2004 - Primary care screening and behavioral counseling interventions for alcohol misuse can be described with

142. The U.S. Preventive Services Task Force: An evidence-based prevention resource for nurse practitioners (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/epbnursep.pdf
     November 01, 2007 - These processes are fully described in a procedure manual and in a series of articles available on the … As described above, quality-of- care indicators document very well the gaps between rec- ommended preventive

143. Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/currprocess.pdf
     July 01, 2007 - emerging scientific issues and current clinical relevance, and then prioritizes them by using the criteria described … Preventive Services Task Force to Ensure Integrity* Goal Process Transparency Standardized methodology described

144. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zWWcTu328Y27Uu4mPt6ZVF
     August 01, 2022 - A fair-quality study (n = 45) in Germany described patient ratings of cosmetic acceptance of deep shave … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

145. Recommendation: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening
     April 18, 2023 - A fair-quality study (n = 45) in Germany described patient ratings of cosmetic acceptance of deep shave … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

146. Screening for Hepatitis B Virus Infection in Pregnancy: Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykFSVS29KAwKzFWSXAVoMY
     June 01, 2009 - Screening for Hepatitis B Virus Infection in Pregnancy: Reaffirmation Recommendation Statement Screening for Hepatitis B Virus Infection in Pregnancy: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement U.S. Preventive Services Task Force* Description: Reaffirmation of the 2004 U.S. Preventive…

147. Screening, Referral, Behavioral Counseling, and Preventive Interventions for Oral Health in Children and Adolescents Aged 5 to 17 Years: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9AtjNaSwTXonz49w_DEbNz
     November 07, 2023 - re- sults from 2 fair-quality trials of xylitol15,16; results of 8 poor-quality xylitol trials are described … study limitations, consistency, precision, report- ing bias, and applicability, using the approach described … All adverse events were described as self-limited, al- though 4 children were withdrawn due to mild adverse … The harms of preventive interventions were sparsely reported, although serious harms were not described

148. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/LNtA2SDWjpsDwjXvsH4F5m
     April 17, 2023 - The study population in the large US trial (n = 2328) of a reduced prenatal visit schedule was described … predominantly White (81%) and Hispanic (12%) individuals.1,38,41 One-third of study participants (32%) were described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

149. Final Research Plan: Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/early-food-allergen-introduction-infants-counseling
     September 05, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling September 05, 2024 Recommendations made by the USPSTF are indepen…

150. Draft Research Plan: Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/early-food-allergen-introduction-infants-counseling
     May 09, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Early Allergen Introduction to Prevent Food Allergies in Infants: Counseling May 09, 2024 Recommendations made by the USPSTF are indepen…

151. Screening and Treatment for Major Depressive Disorder in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MZB7xxWHfLHtcdT9uUHsrp
     April 01, 2009 - Screening and Treatment for Major Depressive Disorder in Children and Adolescents: Recommendation Statement SPECIAL ARTICLE Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force The author has i…

152. Evidence Directions for Primary Care Interventions to Prevent Child Maltreatment (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/tpsQcTR2sDok_YELXgBHFb
     Evidence Directions for Primary Care Interventions to Prevent Child Maltreatment Evidence Directions for Primary Care Interventions to Prevent Child Maltreatment The USPSTF sought evidence linking validated risk assessment and primary care–feasible or referrable interventions to direct or intermediate measures of ch…

153. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
     September 15, 2005 - Models with potential clinical applications 22-24 , 57-72 are described in Table 2 . … population. 168 , 171 Surgical complications attributable to prophylactic oophorectomy are not well described … Diagnostic Accuracy Studies Criteria Screening test relevant, available for primary care, adequately described … Calculation of 95% CI for penetrance in equations 4 and 5 is similar to that described above, with appropriate

154. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
     April 26, 2022 - The aggregate strength of evidence was assessed for each KQ using the approach described in the Methods … sensitivity analyses, 56 , 72 and 6 cohorts reporting serious harm 60 , 67 , 68 , 78 , 79 , 81 , 88 are not described … Trial characteristics are described in eTable 4 in the JAMA Supplement. … major bleeding harms. 5-7 , 26 , 28 , 29 , 31 , 32 , 43 , 45 , 53 , 87 These include the 11 RCTs described

155. Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R33bUm6oyjhWnbw96pJHwE
     April 01, 2009 - Therefore, we used a modified approach to reviewing these abstracts as described in Appendix 2. … Details of our quantitative synthesis approach and rationale are described in detail in Appendix 2. … Studies-Depression Scale; CIS-R, Revised Clinical Interview Schedule. a USPSTF quality criteria are described … Nondirective supportive psychotherapy was considered to be a treatment group unless it was described … Diagnostic accuracy studies Screening test relevant, available for primary care, adequately described

156. Archived: Evidence Update: Prostate Cancer: Screening, 2008 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/article/prostate-cancer-screening-2008
     August 05, 2008 - A 2004 publication described 3 additional years of follow-up of this study. 15 By the end of 1999, 23.6% … Characteristics of patients who chose watchful waiting were not separately described. … studies       Criteria          Screening test relevant, available for primary care, adequately described

157. Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NhXnjZM5ubvygH5GrqDZHC
     August 01, 2008 - A 2004 publication described 3 additional years of follow-up of this study (15). … Characteristics of patients who chose watchful waiting were not separately described. … Diagnostic accuracy studies Criteria Screening test relevant, available for primary care, adequately described

158. Archived: Final Evidence Review: Genital Herpes: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
     March 15, 2005 - Currently available tests are described in Table 1 . … prospective study of asymptomatic HSV-2 seropositive adults randomly tested in family practice clinics described … The analytic framework and key questions guiding the literature searches are described in the Figure … A prospective cohort study described incident cases of both HSV-1 and HSV-2 among HSV-2 seronegative … A summary of evidence considered for this update is described

159. Screening for Genital Herpes Simplex: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZzZp7_aoJn73k9z25w_-qr
     March 01, 2005 - Currently available tests are described in Table 1. … prospective study of asymptomatic HSV-2 seropositive adults randomly tested in family practice clinics described … The analytic framework and key questions guiding the literature searches are described in the Figure. … A prospective cohort study described incident cases of both HSV-1 and HSV-2 among HSV-2 seronegative … Conclusions A summary of evidence considered for this update is described in Table 4.

160. Archived: Evidence Summary: Harms of Screening for Breast Cancer: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-harms-of-screening-for-breast-cancer/breast-cancer-screening-january-2016
     January 11, 2016 - factors considered in this review are common among women who are not at high risk for breast cancer 9 (described … differences in study characteristics, measures, and methods affect estimates of overdiagnosis has been well-described … ) and 10 additional observational studies 44–53 ( Table 2 ) published after the systematic reviews described … Five observational studies described false-positive results with the use of tomosynthesis. … Evidence-based Medicine criteria; based on study design and rates of attrition; methods of synthesis not described